Ramsay Générale de Santé SA (GDS.PA)
EUR 9.68
(-0.41%)
EUR 9.68
(-0.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.65 Billion EUR | -56.42% |
| 2022 | 3.79 Billion EUR | -1.0% |
| 2021 | 3.83 Billion EUR | 18.24% |
| 2020 | 3.24 Billion EUR | -4.09% |
| 2019 | 3.38 Billion EUR | 104.11% |
| 2018 | 1.65 Billion EUR | 74.1% |
| 2017 | 951.3 Million EUR | -2.17% |
| 2016 | 972.4 Million EUR | -7.57% |
| 2015 | 1.05 Billion EUR | 43.19% |
| 2014 | 734.7 Million EUR | -5.05% |
| 2013 | 773.8 Million EUR | -44.07% |
| 2012 | 1.38 Billion EUR | 67.59% |
| 2011 | 825.6 Million EUR | -0.53% |
| 2010 | 830 Million EUR | -3.73% |
| 2009 | 862.2 Million EUR | -3.35% |
| 2008 | 892.1 Million EUR | -19.81% |
| 2007 | 1.11 Billion EUR | 122.5% |
| 2006 | 500 Million EUR | -2.95% |
| 2005 | 515.2 Million EUR | 30.76% |
| 2004 | 394 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 3.7 Billion EUR | -2.52% |
| 2023 Q2 | 3.95 Billion EUR | 7.13% |
| 2023 Q3 | 1.72 Billion EUR | -56.45% |
| 2023 Q4 | 1.65 Billion EUR | -3.94% |
| 2023 Q1 | 3.69 Billion EUR | -2.75% |
| 2022 Q2 | 3.93 Billion EUR | 6.93% |
| 2022 Q3 | 3.52 Billion EUR | -10.4% |
| 2022 Q4 | 3.79 Billion EUR | 7.57% |
| 2022 FY | 3.79 Billion EUR | -1.0% |
| 2022 Q1 | 3.68 Billion EUR | -3.93% |
| 2021 FY | 3.83 Billion EUR | 18.24% |
| 2021 Q1 | 3.28 Billion EUR | 1.4% |
| 2021 Q4 | 3.83 Billion EUR | 6.82% |
| 2021 Q2 | 3.47 Billion EUR | 5.81% |
| 2021 Q3 | 3.58 Billion EUR | 3.17% |
| 2020 Q3 | 3.06 Billion EUR | -0.39% |
| 2020 Q1 | 2.88 Billion EUR | -14.6% |
| 2020 Q2 | 3.07 Billion EUR | 6.52% |
| 2020 Q4 | 3.24 Billion EUR | 5.85% |
| 2020 FY | 3.24 Billion EUR | -4.09% |
| 2019 Q2 | 3.69 Billion EUR | 5.08% |
| 2019 FY | 3.38 Billion EUR | 104.11% |
| 2019 Q1 | 3.51 Billion EUR | 112.48% |
| 2019 Q3 | 3.21 Billion EUR | -13.1% |
| 2019 Q4 | 3.38 Billion EUR | 5.19% |
| 2018 FY | 1.65 Billion EUR | 74.1% |
| 2018 Q4 | 1.65 Billion EUR | 1.29% |
| 2018 Q3 | 1.63 Billion EUR | -29.35% |
| 2018 Q2 | 2.31 Billion EUR | 2.21% |
| 2018 Q1 | 2.26 Billion EUR | 138.02% |
| 2017 Q1 | 1.01 Billion EUR | 3.94% |
| 2017 Q4 | 951.3 Million EUR | 3.75% |
| 2017 Q3 | 916.9 Million EUR | -9.28% |
| 2017 Q2 | 1.01 Billion EUR | 0.0% |
| 2017 FY | 951.3 Million EUR | -2.17% |
| 2016 FY | 972.4 Million EUR | -7.57% |
| 2016 Q4 | 972.4 Million EUR | 3.42% |
| 2016 Q3 | 940.2 Million EUR | -7.58% |
| 2016 Q2 | 1.01 Billion EUR | 0.0% |
| 2016 Q1 | 1.01 Billion EUR | -3.3% |
| 2015 FY | 1.05 Billion EUR | 43.19% |
| 2015 Q2 | 1.09 Billion EUR | 3.89% |
| 2015 Q3 | 1.02 Billion EUR | -6.19% |
| 2015 Q4 | 1.05 Billion EUR | 2.28% |
| 2015 Q1 | 1.05 Billion EUR | 0.0% |
| 2014 Q2 | 760.7 Million EUR | -5.97% |
| 2014 Q1 | 809 Million EUR | 2.28% |
| 2014 FY | 734.7 Million EUR | -5.05% |
| 2013 Q2 | 773.8 Million EUR | -5.38% |
| 2013 Q1 | 817.8 Million EUR | -41.15% |
| 2013 FY | 773.8 Million EUR | -44.07% |
| 2013 Q4 | 791 Million EUR | 31.35% |
| 2013 Q3 | 602.2 Million EUR | -22.18% |
| 2012 FY | 1.38 Billion EUR | 67.59% |
| 2012 Q2 | 1.38 Billion EUR | -1.45% |
| 2012 Q1 | 1.4 Billion EUR | 66.97% |
| 2012 Q4 | 1.38 Billion EUR | 0.67% |
| 2012 Q3 | 1.38 Billion EUR | -0.22% |
| 2011 Q1 | 899.9 Million EUR | 5.61% |
| 2011 Q4 | 840.8 Million EUR | 5.4% |
| 2011 Q3 | 797.7 Million EUR | -3.38% |
| 2011 FY | 825.6 Million EUR | -0.53% |
| 2011 Q2 | 825.6 Million EUR | -8.26% |
| 2010 FY | 830 Million EUR | -3.73% |
| 2010 Q4 | 852.1 Million EUR | 14.67% |
| 2010 Q3 | 743.1 Million EUR | -10.47% |
| 2010 Q2 | 830 Million EUR | -4.34% |
| 2010 Q1 | 867.7 Million EUR | 0.0% |
| 2009 Q2 | 862.2 Million EUR | 0.0% |
| 2009 FY | 862.2 Million EUR | -3.35% |
| 2008 FY | 892.1 Million EUR | -19.81% |
| 2007 FY | 1.11 Billion EUR | 122.5% |
| 2006 FY | 500 Million EUR | -2.95% |
| 2005 FY | 515.2 Million EUR | 30.76% |
| 2004 FY | 394 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Clariane SE | 7.87 Billion EUR | 79.0% |
| LNA Santé SA | 810.5 Million EUR | -104.096% |